BACKGROUNDContinuous renal replacement therapies (CRRTs) are now considered routinely in the treatment of patients with acute kidney injury (AKI) in the intensive care (ICU) setting. In search of the most effective modality, cost becomes important.METHODSOf the various modalities utilizing convection, diffusion, or a combination of the two, continuous venovenous hemodiafiltration (CVVHDF) and extended hemodialysis procedures (including sustained low‐efficiency dialysis [SLED]) are the most common in the United States; both have been noted to be effective in delivering an adequate dialysis dose. This study compared the costs of these two therapies in two Philadelphia teaching hospitals.RESULTSThe cost for delivery of 24 hours of CVVHDF using the Gambro‐Prisma machine was found to be $1,602 versus $423 for 12 hours of SLED therapy with the Fresenius 2008K machine. Twenty‐four hours of SLED would cost $797, and the cost can be decreased to $77 if the nursing‐to‐patient ratio is increased from 1:1 to 1:2.CONCLUSIONSHigher material costs were primarily responsible for the expense of CVVHDF. Given that the dose deliveries are similar, SLED remains the most cost‐effective option for delivering renal replacement in the ICU setting. These costs may not exactly mirror those of other institutions depending on the types of solutions used, the filters utilized, salary differences based on geographical location, and the intensity of CRRT delivered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.